Healthequity Inc

HQY suffered a support failure in late August on high volume, confirming medium-term bearish control. Price is extended below declining 9/20/50 EMAs with rejection at resistance and RSI remains in bearish territory without reversal signals. Execution favors immediate sell-side participation while remaining alert to potential oversold relief rallies into broken support and moving averages.

• ↑Q2 FY27 revenue $350.7M (+8% YoY), net income $65.6M (+10%).
• ↑HSA accounts at 10.7M (+5% YoY); assets hit $37.9B (+14%).
• ↓Healthcare costs rising at near double-digit rates may dampen HSA contributions.